Evidence map›Paper›PMID 34604725›Full record

ArticleJHEP reports : innovation in hepatology2021

Ablation of liver

Noortje Ijssennagger, Kristel S van Rooijen, Stefanía Magnúsdóttir, José M Ramos Pittol, Ellen C L Willemsen, Marcel R de Zoete, Matthijs J D Baars, Paul B Stege, Carolina Colliva, Roberto Pellicciari and 5 more

Open access · goldAbstract read
In one paragraph

Article in JHEP reports : innovation in hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. FXR deletion attenuates intestinal barrier dysfunction in murine acute intestinal inflammation.American journal of physiology. Gastrointestinal and liver physiology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. FXR Friend-ChIPs in the Enterohepatic System.Seminars in liver disease · 2023
    Review
  12. The Role of Microbiota-Derived Metabolites in Colorectal Cancer.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Noortje IjssennaggerDepartment of Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Kristel S van RooijenDepartment of Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Stefanía MagnúsdóttirDepartment of Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
José M Ramos PittolDepartment of Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Ellen C L WillemsenDepartment of Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Marcel R de ZoeteDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Matthijs J D BaarsDepartment of Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Paul B StegeDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Carolina CollivaTES Pharma S.r.l., Perugia, Italy.
Roberto PellicciariTES Pharma S.r.l., Perugia, Italy.
Sameh A YoussefNon-Clinical Safety, Department of Pathology, Janssen Pharmaceutica Research and Development, Beerse, Belgium.
Alain de BruinDepartments of Pediatrics and Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Yvonne VercoulenDepartment of Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Folkert KuipersDepartments of Pediatrics and Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Saskia W C van MilDepartment of Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
University Medical Center Utrecht · NLUniversity Medical Center Groningen · NLJanssen (Belgium) · BEUniversität Innsbruck · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

aimsThe interorgan crosstalk between the liver and the intestine has been the focus of intense research. Key in this crosstalk are bile acids, which are secreted from the liver into the intestine, interact with the microbiome, and upon absorption reach back to the liver. The bile acid-activated farnesoid X receptor (

methodsFxr floxed/floxed mice were crossed with cre-expressing mice to yield

resultsDespite relatively small changes in biliary bile acid concentration and composition, more genes were differentially expressed in the colons of

conclusionsTargeting of LAY SUMMARY: This study shows that the communication of the liver to the intestine is crucial for intestinal health. Bile acids are key players in this liver-to-gut communication, and when

Indexed as

BAs, bile acidsColonDSS, dextran sodium sulfateFarnesoid X receptorFgfr4, fibroblast growth factor receptor 4FITC, fluorescein isothiocyanatefpkm, fragments per kilobase of transcript per million mapped readsFxr, farnesoid X receptorFxr-intKO, intestine-specific Fxr knockoutFxr-livKO, liver-specific Fxr knockoutFxr-totKO, whole body Fxr knockoutGO, Gene OntologyGut microbiomeHID, high-iron diamineIBD, inflammatory bowel diseaseIntestine-specific Fxr-KO mouseKEGG, Kyoto Encyclopedia of Genes and GenomesLiver–gut axisLiver-specific Fxr-KO mouseMucus layerRT qPCR, real-time quantitative PCR

Identifiers

PMID34604725
PMCPMC8463863
OpenAlexW3188851255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.